Triple negative breast cancer (TNBC) is a breast cancer subtype characterized by the
absence of estrogen receptor, progesterone receptor and human epidermal growth factor …

Natural components continue to be an important source for the discovery and development
of novel anticancer agents. Polymethoxyflavones are a class of flavonoids found in citrus …

Background Triple negative breast cancer (TNBC) is a strongly proliferative, relapse prone,
high-mortality subtype of breast cancer. Due to the lack of effective therapeutic targets, the …

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with poor clinical
outcome, and currently no effective targeted therapies are available. Indole compounds …

In this study we evaluate the antitumour activity, the cell cycle arrest and apoptotic properties
of novel lipophilic benzene-fused seven-membered 5-fluorouracil (5-FU) analogs in …

Breast cancer is the leading cause of female mortality worldwide. Although there are several
modern treatments for breast cancer, there is a high rate of recurrence for the majority of …

Abstract Triple-Negative Breast Cancer (TNBC) is a most dangerous breast cancer subtype.
The naturally occurring sesquiterpene lactone, arnicolide D (AD), has proven effective …

The absence of progesterone receptors, estrogen receptors, and human epidermal growth
factor receptor-2 restricts the therapy choices for treating triple-negative breast cancer …

Triple-negative breast cancer (TNBC) is a highly aggressive subtype currently lacking
effective treatment options. Consequently, novel and effective drugs or compounds are …

Background Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer
which is associated with poor patient outcome and lack of targeted therapy. Our laboratory …